DEMARCUS BENJAMIN: Open Payments
NPI 1902574486 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 24 payments from 14 companies in 2025. Trend: 2023 $231 · 2024 $489 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 6 | $109 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: WATCHMAN FLX, JARDIANCE, Ozempic, FUROSCIX, FARXIGA, CAPLYTA, Kerendia, LifeVest.
Industry payments across SC — which companies pay providers there.
